Here are seven things ASC leaders should know for March 27, 2017.
ASC News
The ambulatory services market is likely to continue expanding as ASCs yield cost savings, a Hexa Research firm found, according to medGadget.
Laval, Canada-based Valeant CEO Joe Papa received $62.7 million in compensation for eight months' work amidst a "disappointing" financial year, CBC reports.
Here are 73 statistics on otolaryngology, otolaryngologists and ENT in ASCs.
Durham, N.C.-based Duke University researchers found an interdisciplinary treatment modality approach to pain management was effective in treating pain and was cost effective, according to Pharmacy Times.
Advertisement
As a leader in the surgery center industry, Summit Orthopedics Vadnais Heights (Minn.) Surgery Center is making great headway in the number of total joint procedures its providers perform, Press Pubs reports.
Here are seven updates for healthcare and ASC leaders to note:
Dublin, Ireland-based Allergan's Juvederm Vollure received FDA approval.
An RNnetowrk survey polled nurses on their reasons for leaving the profession as almost 50 percent of those surveyed reported considering leaving nursing at one point.
The cataract surgery devices market is growing globally due to a range of factors, as reported by a Future Market Insights report, according to medGadget.